Social Media



Effective cancer care means that patients receive appropriate, timely care, based on best evidence. To ensure the best possible clinical outcomes and that patients goals of care are met, clinical guidance and new knowledge need to be implemented into practice as quickly as possible. 

We need to improve our understanding about whether the care we provide is improving outcomes. We need to ensure new evidence is promptly evaluated, and that best-practice guidelines are consistently used in practice. We will support the use of evidence-based guidelines, and work with our partners to align efforts in areas such as personalized medicine.


Image of Lianne D.

“For patients, our symptoms define our illness. We just want to feel better, to be able to get back to our lives. I had to blindly trust a doctor I had never met before to look after me, to believe in what he told me would be the most effective treatment for me. I am incredibly lucky to be alive today, but I still have lingering side effects from that treatment.”

Lianne's story All stories

Ensure the provision of effective cancer care based on best evidence

Strategic Objectives

  • Expand measurement of outcomes to enable effective, high-quality care.
  • Expand our performance management model to include non-hospital healthcare organizations and performance at the provider level in order to be more effective with our quality and access programs across the system.
  • Leverage and expand the use of evidence-based guidance to improve the appropriateness of care.
  • Develop a unifying strategy for personalized medicine for cancer care including personal and tumor genetics and incorporate recommendations into clinical practice.

By 2019

  • Standards, guidelines and programming for patient care will be informed and developed using enhanced measures of clinical and patient-reported outcomes for colorectal and breast cancers.
  • We will use system-level indicators to compare the performance of Ontario’s cancer system against international benchmarks.
  • Our performance management and evaluation system will be expanded beyond the hospital setting.
  • Individual healthcare providers and facilities will have access to performance data to drive improvements in care.
  • Our funding levers will be used to align care with evidence-based guidelines for mammography, upper gastrointestinal endoscopy, colonoscopy, colposcopy, systemic treatment, cancer surgery, radiation, diagnostics and other specialized services. 
  • In conjunction with our partners, we will begin the implementation of the personalized medicine strategy for cancer care in Ontario.

Examples of Initiatives

  • Implement new funding models for systemic treatment, upper gastrointestinal endoscopy, colonoscopy, colposcopy, cancer surgery and radiation, and further develop our leadership in funding model methodologies.
  • Promote imaging appropriateness by endorsing guidelines, measuring guideline concordance and implementing technical imaging standards.
  • Expand the use of pathway maps with a focus on measuring system performance and patient outcomes by disease site.